{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:10:20Z","timestamp":1770819020804,"version":"3.50.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T00:00:00Z","timestamp":1431043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0125726","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T18:04:16Z","timestamp":1431108256000},"page":"e0125726","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Resveratrol Ameliorates Renal Damage, Increases Expression of Heme Oxygenase-1, and Has Anti-Complement, Anti-Oxidative, and Anti-Apoptotic Effects in a Murine Model of Membranous Nephropathy"],"prefix":"10.1371","volume":"10","author":[{"given":"Chia-Chao","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Sung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Shuen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sui-Lung","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuh-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauling","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huey-Kang","family":"Sytwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,8]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2001.0590051983.x","article-title":"Idiopathic membranous glomerulonephritis","volume":"59","author":"DC Cattran","year":"2001","journal-title":"Kidney Int"},{"issue":"4","key":"ref2","first-page":"324","article-title":"Diagnosis and natural course of membranous nephropathy","volume":"23","author":"RJ Glassock","year":"2003","journal-title":"SeminNephrol"},{"issue":"3","key":"ref3","first-page":"258","article-title":"New insights into the pathogenesis of membranous glomerulonephritis","volume":"15","author":"P Ronco","year":"2006","journal-title":"CurrOpinNephrolHypertens"},{"key":"ref4","first-page":"517","article-title":"Pathogenesis of membranous nephropathy","volume":"39","author":"WG Couser","year":"1988","journal-title":"AnnuRevMed"},{"issue":"5","key":"ref5","first-page":"1195","article-title":"Cellular response to injury in membranous nephropathy","volume":"16","author":"M Nangaku","year":"2005","journal-title":"JAmSocNephrol"},{"issue":"5","key":"ref6","first-page":"1188","article-title":"Management of membranous nephropathy: when and what for treatment","volume":"16","author":"D Cattran","year":"2005","journal-title":"JAmSocNephrol"},{"issue":"3","key":"ref7","first-page":"562","article-title":"The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum?","volume":"44","author":"RJ Glassock","year":"2004","journal-title":"AmJKidney Dis"},{"issue":"6","key":"ref8","first-page":"1012","article-title":"Idiopathic membranous nephropathy: outline and rationale of a treatment strategy","volume":"46","author":"PW du Buf-Vereijken","year":"2005","journal-title":"AmJKidney Dis"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/FJC.0b013e3181bfaff3","article-title":"Grapes, wines, resveratrol, and heart health","volume":"54","author":"AA Bertelli","year":"2009","journal-title":"Journal of cardiovascular pharmacology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphar.2012.00141","article-title":"Resveratrol: French paradox revisited","volume":"3","author":"B Catalgol","year":"2012","journal-title":"Frontiers in pharmacology"},{"issue":"8808","key":"ref11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/0140-6736(92)91277-F","article-title":"Wine, alcohol, platelets, and the French paradox for coronary heart disease","volume":"339","author":"S Renaud","year":"1992","journal-title":"Lancet"},{"issue":"8","key":"ref12","first-page":"1005","article-title":"From resveratrol to its derivatives: new sources of natural antioxidant","volume":"20","author":"S He","year":"2013","journal-title":"Current medicinal chemistry"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4161\/oxim.3.2.11147","article-title":"Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety","volume":"3","author":"P Kovacic","year":"2010","journal-title":"Oxid Med Cell Longev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1749-6632.2010.05848.x","article-title":"Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease","volume":"1215","author":"A Csiszar","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mnfr.200500022","article-title":"Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications","volume":"49","author":"CA de la Lastra","year":"2005","journal-title":"Molecular nutrition & food research"},{"issue":"20","key":"ref16","first-page":"7456","article-title":"Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models","volume":"61","author":"KP Bhat","year":"2001","journal-title":"Cancer research"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2007-967173","article-title":"Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins","volume":"73","author":"CC Wu","year":"2007","journal-title":"Planta medica"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jnutbio.2005.01.017","article-title":"Resveratrol as an anticancer nutrient: molecular basis, open questions and promises","volume":"16","author":"P Signorelli","year":"2005","journal-title":"The Journal of nutritional biochemistry"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/01635581.2012.667862","article-title":"The anticancer effects of resveratrol: modulation of transcription factors","volume":"64","author":"NC Whitlock","year":"2012","journal-title":"Nutrition and cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2010.05854.x","article-title":"Resveratrol: a cardioprotective substance","volume":"1215","author":"JM Wu","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-642-38007-5_10","article-title":"Resveratrol: from basic studies to bedside","volume":"159","author":"A Borriello","year":"2014","journal-title":"Cancer treatment and research"},{"issue":"7117","key":"ref22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"JA Baur","year":"2006","journal-title":"Nature"},{"issue":"11","key":"ref23","first-page":"2721","article-title":"Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences","volume":"19","author":"JS Chen","year":"2004","journal-title":"NephrolDialTransplant"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1258\/la.2007.06016e","article-title":"Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events","volume":"42","author":"CC Wu","year":"2008","journal-title":"Lab Anim"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.ki.5002426","article-title":"Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy","volume":"72","author":"CC Wu","year":"2007","journal-title":"Kidney Int"},{"issue":"10","key":"ref26","first-page":"3082","article-title":"HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects","volume":"23","author":"CC Wu","year":"2008","journal-title":"NephrolDialTransplant"},{"issue":"1","key":"ref27","first-page":"138","article-title":"Pathogenic role of effector cells and immunoglobulins in cationic bovine serum albumin-induced membranous nephropathy","volume":"32","author":"CC Wu","year":"2012","journal-title":"JClinImmunol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2014.08.077","article-title":"Urinary Xist is a potential biomarker for membranous nephropathy","volume":"452","author":"YS Huang","year":"2014","journal-title":"Biochemical and biophysical research communications"},{"key":"ref29","first-page":"639541","article-title":"Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1","volume":"2013","author":"Y Son","year":"2013","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbadis.2011.03.008","article-title":"Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling","volume":"1812","author":"P Palsamy","year":"2011","journal-title":"Biochimica et biophysica acta"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"F660","DOI":"10.1152\/ajprenal.00437.2004","article-title":"Experimental membranous nephropathy redux","volume":"289","author":"AV Cybulsky","year":"2005","journal-title":"AmJPhysiol Renal Physiol"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1096\/fj.09-130542","article-title":"Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities","volume":"23","author":"PD Issuree","year":"2009","journal-title":"Faseb J"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF02976761","article-title":"Anticomplementary activity of stilbenes from medicinal plants","volume":"21","author":"SR Oh","year":"1998","journal-title":"Archives of pharmacal research"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1089\/ars.2009.3064","article-title":"Antioxidant and anti-inflammatory effects of resveratrol in airway disease","volume":"13","author":"LG Wood","year":"2010","journal-title":"Antioxidants & redox signaling"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"568093","DOI":"10.1155\/2013\/568093","article-title":"Renal protective effects of resveratrol","volume":"2013","author":"M Kitada","year":"2013","journal-title":"Oxidative medicine and cellular longevity"},{"issue":"25","key":"ref36","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/S0024-3205(01)01061-X","article-title":"Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats","volume":"68","author":"T Nihei","year":"2001","journal-title":"Life sciences"},{"issue":"3","key":"ref37","first-page":"133","article-title":"Plasma and tissue resveratrol concentrations and pharmacological activity","volume":"24","author":"A Bertelli","year":"1998","journal-title":"Drugs under experimental and clinical research"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mnfr.200900437","article-title":"Resveratrol bioavailability and toxicity in humans","volume":"54","author":"CH Cottart","year":"2010","journal-title":"Molecular nutrition & food research"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1124\/dmd.104.000885","article-title":"High absorption but very low bioavailability of oral resveratrol in humans","volume":"32","author":"T Walle","year":"2004","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0125726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T17:40:54Z","timestamp":1589046054000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0125726"}},"subtitle":[],"editor":[{"given":"Udai P.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,8]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0125726","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,8]]}}}